DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 02 · Volume 49 · März 2016 DOI: 10.1055/s-006-31169

Original Paper

45
Merrill, R. M.; Thygerson, S. M.; Palmer, C. A.: Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy
51
Ryu, S.; Huh, I.-S.; Cho, E.-Y.; Cho, Y.; Park, T.; Yoon, S. C.; Joo, Y. H.; Hong, K. S.: Association Study of 60 Candidate Genes with Antipsychotic-induced Weight Gain in Schizophrenia Patients
Supporting Information
57
Gahr, M.; Eller, J.; Connemann, B. J.; Schönfeldt-Lecuona, C.: Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care
Supporting Information
62
McKibben, C. E.; Reynolds, G. P.; Jenkins, T. A.: Concurrent Risperidone Administration Attenuates the Development of Locomotor Sensitization Following Sub-Chronic Phencyclidine in Rats
66
Soyka, M.; Friede, M.; Schnitker, J.: Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences?
Results from an Indirect Meta-Analysis
76
Mittag, N.; Meister, S.; Berg, A. M. J.; Walther, U. I.: A Case Report of a Carbamazepine Overdose With Focus on Pharmacokinetic Aspects

Letter to the Editor

79
Kellner, M.; Nowack, S.; Wortmann, V.; Yassouridis, A.; Wiedemann, K.: Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? – A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study